You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

LORELCO Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Lorelco, and when can generic versions of Lorelco launch?

Lorelco is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in LORELCO is probucol. There are six drug master file entries for this compound. Additional details are available on the probucol profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LORELCO?
  • What are the global sales for LORELCO?
  • What is Average Wholesale Price for LORELCO?
Summary for LORELCO
Drug patent expirations by year for LORELCO
Recent Clinical Trials for LORELCO

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Otsuka Beijing Research InstitutePhase 1
Otsuka Beijing Research InstitutePhase 3
Otsuka Beijing Research InstituteN/A

See all LORELCO clinical trials

US Patents and Regulatory Information for LORELCO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us LORELCO probucol TABLET;ORAL 017535-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sanofi Aventis Us LORELCO probucol TABLET;ORAL 017535-002 Jul 6, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for LORELCO

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us LORELCO probucol TABLET;ORAL 017535-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Sanofi Aventis Us LORELCO probucol TABLET;ORAL 017535-002 Jul 6, 1988 ⤷  Sign Up ⤷  Sign Up
Sanofi Aventis Us LORELCO probucol TABLET;ORAL 017535-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.